within Pharmacolibrary.Drugs.ATC.M;

model M05BC02
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0,
    Cl             = 0.0,
    adminDuration  = 600,
    adminMass      = 0.0,
    adminCount     = 1,
    Vd             = 0,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Eptotermin alfa, also known as recombinant human bone morphogenetic protein-7 (rhBMP-7), is a bone morphogenetic protein used to stimulate bone growth in non-union fractures and certain spinal fusions. It was previously approved for orthopedic use but is no longer widely marketed or approved today in most countries.</p><h4>Pharmacokinetics</h4><p>No pharmacokinetic model parameters have been published in the scientific literature for eptotermin alfa (rhBMP-7) in humans.</p><h4>References</h4><ol></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end M05BC02;
